These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Levy JH, Welsby I, Goodnough LT. Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955 [Abstract] [Full Text] [Related]
5. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial. Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M. J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777 [Abstract] [Full Text] [Related]
6. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Mittermayr M, Streif W, Haas T, Fries D, Velik-Salchner C, Klingler A, Oswald E, Bach C, Schnapka-Koepf M, Innerhofer P. Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365 [Abstract] [Full Text] [Related]
7. In vitro efficacy of RiaSTAP after rapid reconstitution. Karri JV, Cardenas JC, Johansson PI, Matijevic N, Cotton BA, Wade CE, Holcomb JB. J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482 [Abstract] [Full Text] [Related]
8. Impaired thrombin generation and fibrin clot formation in patients with dilutional coagulopathy during major surgery. Schols SE, Lancé MD, Feijge MA, Damoiseaux J, Marcus MA, Hamulyák K, Ten Cate H, Heemskerk JW, van Pampus EC. Thromb Haemost; 2010 Feb; 103(2):318-28. PubMed ID: 20024495 [Abstract] [Full Text] [Related]
9. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products. Tang M, Fenger-Eriksen C, Wierup P, Greisen J, Ingerslev J, Hjortdal V, Sørensen B. Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748 [Abstract] [Full Text] [Related]
10. Fibrinogen as a hemostatic agent. Sørensen B, Larsen OH, Rea CJ, Tang M, Foley JH, Fenger-Eriksen C. Semin Thromb Hemost; 2012 Apr; 38(3):268-73. PubMed ID: 22460909 [Abstract] [Full Text] [Related]
12. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit. Motta M, Del Vecchio A, Radicioni M. J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611 [Abstract] [Full Text] [Related]
16. Severe bleeding in surgical and trauma patients: the role of fibrinogen replacement therapy. Spahn DR. Thromb Res; 2012 Dec; 130 Suppl 2():S15-9. PubMed ID: 23439002 [Abstract] [Full Text] [Related]
17. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Sørensen B, Bevan D. Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356 [Abstract] [Full Text] [Related]
18. Use of fibrin sealant as a hemostatic agent in expanded polytetrafluoroethylene graft placement surgery. Saha SP, Muluk S, Schenk W, Burks SG, Grigorian A, Ploder B, Presch I, Pavlova BG, Hantak E. Ann Vasc Surg; 2011 Aug; 25(6):813-22. PubMed ID: 21514114 [Abstract] [Full Text] [Related]
19. Management of surgical hemostasis: systemic agents. Levy JH, Tanaka KA. Vascular; 2008 Aug; 16 Suppl 1():S14-21. PubMed ID: 18544301 [Abstract] [Full Text] [Related]
20. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Schöchl H, Forster L, Woidke R, Solomon C, Voelckel W. Anaesthesia; 2010 Feb; 65(2):199-203. PubMed ID: 19995349 [Abstract] [Full Text] [Related] Page: [Next] [New Search]